Triangle3-Fraction HDR Brachytherapy (NCT07022470)
3-Fraction HDR Brachytherapy trial for Cervical Cancers (NCT07022470). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with cervical cancer scheduled for definitive brachytherapy. MRI and radiation must be suitable; prior pelvic radiation restrictions apply.
The idea: the first treatment plan determines the schedule. Patients who meet tumor-coverage and nearby-organ limits receive three sessions of eight gray. Others receive four sessions of seven gray. Assignment is not random. Researchers measure how many patients can receive the shorter course, and assess safety and cancer control.
This phase 2 study plans 41 patients. Elizabeth Kidd leads at Stanford, Palo Alto, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.